Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Liabilities: 2012-2025

Historic Total Liabilities for Veracyte (VCYT) over the last 12 years, with Sep 2025 value amounting to $110.1 million.

  • Veracyte's Total Liabilities rose 11.26% to $110.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.1 million, marking a year-over-year increase of 11.26%. This contributed to the annual value of $124.1 million for FY2024, which is 75.23% up from last year.
  • Veracyte's Total Liabilities amounted to $110.1 million in Q3 2025, which was down 10.51% from $123.0 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Total Liabilities ranged from a high of $124.1 million in Q4 2024 and a low of $50.9 million during Q1 2021.
  • Over the past 3 years, Veracyte's median Total Liabilities value was $99.0 million (recorded in 2024), while the average stood at $96.0 million.
  • In the last 5 years, Veracyte's Total Liabilities spiked by 154.13% in 2021 and then declined by 14.18% in 2023.
  • Over the past 5 years, Veracyte's Total Liabilities (Quarterly) stood at $91.3 million in 2021, then decreased by 11.05% to $81.2 million in 2022, then declined by 12.83% to $70.8 million in 2023, then spiked by 75.23% to $124.1 million in 2024, then increased by 11.26% to $110.1 million in 2025.
  • Its Total Liabilities stands at $110.1 million for Q3 2025, versus $123.0 million for Q2 2025 and $120.5 million for Q1 2025.